drugset
drugset / Trial / NCT01755676

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

NCT01755676 ↗

Phase 3 Completed 638 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate efficacy of orlistat 60 mg as adjuvant treatment of Obesity in adults.

Timeline

Start
2016-09
Primary completion
2017-12
Completion
2017-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Orlistat Small molecule 60 mg —

Indications

obesity disorder